CVM ($CVM) Insider Trading & Smart Money Activity

CVM · Biotechnology · Latest filing Jun 30, 2026

$CVM has 3 insider trades on file. Insiders filed 3 Form 4 transactions in the last 12 months, none of them open-market purchases or sales.

Insider buyers (12 mo): 0
Insider sellers (12 mo): 0
Net insider $ (12 mo): $0
Congress trades (12 mo): 0
13F moves on file: 0
Analyst ratings on file: 0

CVM insider buying and selling by quarter

Quarter	Congress buys / sales	13F added / cut
Q1 2026	0 / 0	0 / 0
Q2 2026	0 / 0	0 / 0
Q3 2026	0 / 0	0 / 0
Q4 2026	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All CVM insider, congress, 13F and analyst activity

Date	Source	Who	Action	Shares	Value / amount	1W	1M	Story
Jun 30, 2026	Insider	Eyal TalorChief Scientific Officer	Buy (Grant or award)	2.31K sh	$2.40K	+23.1%	+17.3%	Read
Jun 30, 2026	Insider	Patricia PrichepChief Financial Officer	Buy (Grant or award)	4.12K sh	$4.29K	+23.1%	+17.3%	Read
Jun 30, 2026	Insider	Geert KerstenChief Executive Officer	Buy (Grant or award)	5.19K sh	$5.40K	+23.1%	+17.3%	Read

1W / 1M / 6M = how CVM moved from the trade or filing date.

Insider trading in CVM: who is buying and selling

Insider	Role	Trades	Open-market net	Last trade
Eyal Talor	Chief Scientific Officer	1	—	Jun 30, 2026
Patricia Prichep	Chief Financial Officer	1	—	Jun 30, 2026
Geert Kersten	Chief Executive Officer	1	—	Jun 30, 2026

Frequently asked questions

What is the latest insider trade in CVM?

Eyal Talor, Chief Scientific Officer filed a buy (grant or award) of 2.31K sh worth $2.40K on Jun 30, 2026.

Other biotechnology stocks

All stocks Insider cluster buys Top insider purchases Congress 13F institutions

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text